Matever
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Matever, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: EMA Authorised: Matever (levetiracetam) — Pharmathen S.A.
1 regulatory and trial event tracked for Matever, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: EMA Authorised: Matever (levetiracetam) — Pharmathen S.A.